GSK_Annual_Report_2021

Notes to the Standalone Financial Statements for the year ended March 31, 2021 (contd.) Annual Report 2020-21 143 (ii) Details relating to parties referred to in items 1(i), 1(ii) and 1(iii) above: ( ` in lakhs) Holding company/ ultimate holding company 1(i) Subsidiary of the company 1(ii) Other companies in the GSK Group 1(iii) Year ended March 31, 2021 Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2020 Year ended March 31, 2021 Year ended March 31, 2020 1 Purchase of materials/traded goods - - 3,62.48 - 619,20.62 634,52.35 2 Sale of materials/sale of products - - - - 63.17 23.92 3 Sale of laptops - - - - - 28.56 4 Expenses recharged to other companies - 36.05 29.89 35.34 26,95.55 27,93.64 5 Expenses recharged by other companies 49.56 - - - 96,35.07 74,67.46 6 Manufacturing charges recovered - - 4,65.95 - 4,31.95 13,84.54 7 Clinical research and data management recoveries - - - - 9,36.45 8,98.26 8 Liabilities written back - - - - 77.24 - 9 Employee benefit liabilities transferred to a related party - - - - 19.86 13.51 10 Outstanding receivables at the period end - - 4,04.06 - 7,29.68 7,30.82 11 Outstanding payables at the period end 46.17 - - 35.58 118,94.44 56,77.24 12 Cross charges recoverable at the period end - - - - 4.82 1,25.22 (iii) Disclosure in respect of material transactions with parties referred to in item 1 (i), 1(ii) and 1(iii) above: ( ` in lakhs) Year ended March 31, 2021 Year ended March 31, 2020 (a) Purchase of materials/traded goods: GlaxoSmithKline Asia Private Limited, India 1,80.74 15,78.80 GlaxoSmithKline Biologicals S.A., Belgium 540,30.11 497,07.76 Biddle Sawyer Limited 3,62.48 - Stiefel India Private Limited, India 10,51.03 29,26.99 GlaxoSmithKline Export Limited, U.K. 66,58.74 85,60.10 (b) Sale of materials/sale of products: GlaxoSmithKline Trading Services Limited, Ireland 63.17 23.92 (c) Expenses recharged to other companies: GlaxoSmithKline Asia Private Limited, India 5,74.13 9,02.47 GSK India Global Services Private Limited 2,89.03 - GSK Pharmaceuticals Pvt. Ltd. , Srilanka 36.73 - GlaxoSmithKline Pharmaceuticals S.A., Belgium 5.65 17.37 GlaxoSmithKline Export Limited, U.K. 4,15.60 4,70.03 GlaxoSmithKline Biologicals S.A., Belgium 1,60.00 78.21